InvestorsHub Logo
Followers 45
Posts 892
Boards Moderated 0
Alias Born 12/01/2010

Re: TenKay post# 2051

Wednesday, 04/18/2018 10:54:30 AM

Wednesday, April 18, 2018 10:54:30 AM

Post# of 44766
Accumulated deficit is $8.4M. That expenditure has developed third party tested and proven technology, acquired a pending cannabis applicant in Texas and took the Company public. How does that compare to OTC peers in the cannabis space still in development stage?

O/S and float are still manageable with the right developments in place. Burn rate is low. Past guidance is irrelevant, the Company ceased and discontinued those non-performing efforts.

The Company's current plan is disclosed, provides a clear path to both assets and revenue and simply needs to be funded. Hence the current registration effort.

You've always pointed out the negative, which is fair. But it's not fair to discount the positive.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INQD News